Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies.

Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies.

Item
http://www.wikidata.org/entity/Q34249389
Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitalsClinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-AnalysesAntimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.Characterization of integrons among Escherichia coli in a region at high incidence of ESBL-EC.Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.Antibiotic resistance in cancer patients.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies.Admissions for antibiotic-resistant infections in cancer patients during first year of cancer diagnosis: a cross-sectional study.Prevalence and risk factors for CTX-M gram-negative bacteria in hospitalized patients at a tertiary care hospital in Kilimanjaro, Tanzania.An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum β-lactamase-producing lineage in the Copenhagen area.
P2860

Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies.

Item
http://www.wikidata.org/entity/Q34249389
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Molecular analysis and risk fa ...... in hematological malignancies.
@ast
Molecular analysis and risk fa ...... in hematological malignancies.
@en
Molecular analysis and risk fa ...... in hematological malignancies.
@nl
type
label
Molecular analysis and risk fa ...... in hematological malignancies.
@ast
Molecular analysis and risk fa ...... in hematological malignancies.
@en
Molecular analysis and risk fa ...... in hematological malignancies.
@nl
prefLabel
Molecular analysis and risk fa ...... in hematological malignancies.
@ast
Molecular analysis and risk fa ...... in hematological malignancies.
@en
Molecular analysis and risk fa ...... in hematological malignancies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Molecular analysis and risk fa ...... in hematological malignancies.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0035780
P407
P433
P478
P577
P5875
P698
P932